ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,728Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 807

$1.01M Total Retail Price of All Prescriptions

Rank: 6 out of 807

891 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 891 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 891 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 17,276 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 1,048 989 1 3
LISINOPRIL 928 872 2 2
OMEPRAZOLE 913 882 3 4
SIMVASTATIN 885 839 4 1
FUROSEMIDE 619 598 5 6
METOPROLOL TARTRATE 587 556 6 8
PRAVASTATIN SODIUM 399 383 7 21
METFORMIN HCL 391 328 8 12
CARVEDILOL 362 330 9 35
HYDROCHLOROTHIAZIDE 345 311 10 9
AMLODIPINE BESYLATE 339 311 11 5
METOPROLOL SUCCINATE 333 316 12 13
MELOXICAM 324 283 13 105
CRESTOR 317 300 14 32
POTASSIUM CHLORIDE 314 285 15 18
PREDNISONE 295 286 16 24
ATENOLOL 278 278 17 7
SERTRALINE HCL 265 265 18 22
LOSARTAN POTASSIUM 248 233 19 14
GABAPENTIN 233 184 20 16
TRAMADOL HCL 227 191 21 19
JANTOVEN 225 217 22 37
DONEPEZIL HCL 222 222 23 31
CARBIDOPA-LEVODOPA 213 213 24 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 187 25 28
ROPINIROLE HCL 200 174 25 95
ZOLPIDEM TARTRATE 200 182 25 23
LANTUS 175 164 28 45
WARFARIN SODIUM 168 162 29 10
TRIAMTERENE-HCTZ 151 151 30 29
CEPHALEXIN 143 139 31 135
TAMSULOSIN HCL 142 135 32 27
ATORVASTATIN CALCIUM 142 128 32 11
PAROXETINE HCL 136 132 34 49
FAMOTIDINE 134 115 35 90
LANTUS SOLOSTAR 130 104 36 42
HYDROCODONE-ACETAMINOPHEN 128 114 S3 37 15
ZETIA 123 118 38 59
ISOSORBIDE MONONITRATE ER 119 116 39 36
CLOPIDOGREL 113 103 40 47
CITALOPRAM HBR 108 108 41 17
ADVAIR DISKUS 106 102 42 33
DIOVAN 105 99 43 46
CIPROFLOXACIN HCL 97 94 44 72
GLIPIZIDE 92 65 45 58
FINASTERIDE 89 89 46 89
SPIRIVA 89 84 46 50
PLAVIX 87 78 48 60
AMOXICILLIN 86 79 49 145
ACETAMINOPHEN-CODEINE 84 70 S3 50 93
GLIPIZIDE ER 84 75 50 67
ALENDRONATE SODIUM 81 79 52 20
LOVASTATIN 80 80 53 39
LOSARTAN-HYDROCHLOROTHIAZIDE 80 80 53 55
NOVOLOG 75 63 55 84
TRAZODONE HCL 74 53 56 25
METHOTREXATE 73 70 57 86
FLUOXETINE HCL 72 67 58 52
DIGOXIN 71 70 59 41
NOVOLOG FLEXPEN 70 59 60 75
PROAIR HFA 69 57 61 43
SYMBICORT 69 65 61 116
PANTOPRAZOLE SODIUM 68 59 63 44
ALLOPURINOL 67 46 64 26
INSULIN SYRINGE 67 60 64 102
NAMENDA 66 66 66 54
AMIODARONE HCL 64 64 67 164
LEVETIRACETAM 64 44 67 119
NEXIUM 62 50 69 68
PEN NEEDLE 62 54 69 63
TRIAMCINOLONE ACETONIDE 58 58 71 98
NOVOFINE AUTOCOVER 55 53 72 224
CYMBALTA 54 29 73 73
GLIPIZIDE XL 52 51 74 94
SPIRONOLACTONE 52 46 74 48
DIOVAN HCT 52 52 74 166
VYTORIN 52 52 74 171
RAMIPRIL 50 50 78 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.